How Do Institutional Review Boards Apply the Federal Risk and Benefit Standards for Pediatric Research

JAMA

Volumn 291, Issue 4, 2004, Pages 476-482

  Shah, Seema ^a   Whittle, Amy ^a   Wilfond, Benjamin ^a,b   Gensler, Gary ^c   Wendler, David ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; ELECTROMYOGRAM; HUMAN; MEDICAL RESEARCH; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK BENEFIT ANALYSIS; STANDARD; UNITED STATES;

EID: 1642458616     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.4.476     Document Type: Article

References (27)

1. American Academy of Pediatrics. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Available at: http//:www.aap.org /policy/00655.html. Accessibility verified December 29, 2003.
2. Center for Drug Evaluation and Research and US Food and Drug Administration. Offices of Drug Evaluation Statistical Report. Rockville, Md: US Dept of Health and Human Services; 1989. Publication 89-233530.
3. Steinbrook R, Testing medications in children. N Engl J Med. 2002;347:1462-1470.
4. §505A of the Food and Drug Administration Modernization Act of 1997. Available at: http://www.fda .gov/opacom/7modact.html. Accessibility verified December 29, 2003.
5. NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. Available at: http://www.nih.gov/grants/guide /notice-files/not98-024.html. Accessibility verified December 29, 2003.
6. Clinical Trials Web site. Available at: http: //clinicaltrials.gov/ct/gui. Accessibility verified December 29, 2003.
7. Food and Drug Administration and the Center for Drug Evaluation and Research. Pediatric drug development. Available at: http://www.fda.gov /cder/pediatric. Accessibility verified December 29, 2003.
8. Food and Drug Administration, Pediatric Exclusivity Provision: January 2001 status report to Congress. Available at: http://www.fda.gov/cder/pediatric /reportcong01.pdf. Accessibility verified December 29, 2003.
9. Bartholome W. Ethics of non-therapeutic clinical research on children. In: Appendix to Report Recommendations: Research Involving Children. Washington, DC: US Government Printing office; 1977:3.1-3.22.
10. Ackerman TF. Moral duties of parents and non-therapeutic clinical research procedures involving children. Bioethics Q. 1980;2:94-111.
11. Brock DW. Ethical issues in exposing children to risks in research. in: Grodin MA, Glantz LH, eds. Children as Research Subjects: Science, Ethics and Law. New York, NY: Oxford University Press; 1994:81-101.
12. Glantz LH. Research with children. Am J Law Med. 1998;24:213-244.
13. Freedman B, Fuks A, Weijer C. In loco parentis: minimal risk as an ethical threshold for research upon children. Hastings Cent Rep. 1993;23:13-19.
14. Department of Health and Human Services. 45 CFR §46. Revised June 18, 1991.
15. Food and Drug Administration. 21 CFR §50.53.
16. Department of Health and Human Services. 45 CFR §46.405. Revised June 18, 1991.
17. Department of Health and Human Services. 45 CFR §46.404. Revised June 18, 1991.
18. Department of Health and Human Services. 45 CFR §46.406. Revised June 18, 1991.
19. Department of Health and Human Services. 45 CFR §46.102(i). Revised June 18, 1991.
20. Janofsky J, Starfield B. Assessment of risk in research on children. J Pediatr. 1981;98:842-846.
21. Forum on Child and Family Statistics. America's children: key national indicators of child well-being 2001. Available at: http://www.childstats.gov/order .asp#AC00. Accessibility verified December 29, 2003.
22. Wennberg J, Gittelsohn A. Small area variations in health care delivery. Science. 1973;182:1102-1108.
23. Bunker JP, Wennberg JE. Operation rates, mortality statistics and the quality of life. N Engl J Med. 1973;289:1249-1251.
24. Office for the Protection from Research Risks. Protecting Human Research Subjects: Institutional Review Board Guidebook. Washington, DC: US Government Printing Office; 1993.
25. King NM. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics. 2000;28:332-343.
26. National Bioethics Advisory Commission. Ethical and policy issues in research involving human participants. Available at: http://www.georgetown.edu /research/nrcbl/nbac/human/overvoll.pdf. Accessibility verified December 29, 2003.
27. Kopelman LM. Children as research subjects: a dilemma. J Med Philos. 2000;25:745-764.